BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

509 related articles for article (PubMed ID: 4033716)

  • 1. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus.
    Cameron AJ; Ott BJ; Payne WS
    N Engl J Med; 1985 Oct; 313(14):857-9. PubMed ID: 4033716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenocarcinoma and Barrett's esophagus. An overrated risk?
    Spechler SJ; Robbins AH; Rubins HB; Vincent ME; Heeren T; Doos WG; Colton T; Schimmel EM
    Gastroenterology; 1984 Oct; 87(4):927-33. PubMed ID: 6468881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus.
    Katz D; Rothstein R; Schned A; Dunn J; Seaver K; Antonioli D
    Am J Gastroenterol; 1998 Apr; 93(4):536-41. PubMed ID: 9576444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors, DNA damage, and disease progression in Barrett's esophagus.
    Olliver JR; Hardie LJ; Gong Y; Dexter S; Chalmers D; Harris KM; Wild CP
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):620-5. PubMed ID: 15767340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenocarcinoma in Barrett's esophagus after elimination of gastroesophageal reflux.
    Hamilton SR; Hutcheon DF; Ravich WJ; Cameron JL; Paulson M
    Gastroenterology; 1984 Feb; 86(2):356-60. PubMed ID: 6690363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma.
    Avidan B; Sonnenberg A; Schnell TG; Chejfec G; Metz A; Sontag SJ
    Am J Gastroenterol; 2002 Aug; 97(8):1930-6. PubMed ID: 12190156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does screening for Barrett's esophagus and adenocarcinoma of the esophagus prolong survival?
    Dellon ES; Shaheen NJ
    J Clin Oncol; 2005 Jul; 23(20):4478-82. PubMed ID: 16002837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Adenocarcinoma in Barrett's esophagus: long-term results of curative resection].
    Peracchia A; Bonavina L; Pavanello M; Montorsi M; Ruol A; Segalin A
    Chir Ital; 1994; 46(3):1-4. PubMed ID: 7528110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Molecular alterations in Barrett's esophagus and adenocarcinoma].
    Ozawa S; Ando N; Kitagawa Y; Ueda M; Kitajima M
    Nihon Geka Gakkai Zasshi; 1999 Mar; 100(3):235-9. PubMed ID: 10379532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barrett's metaplasia and dysplasia in postmyotomy achalasia patients.
    Feczko PJ; Ma CK; Halpert RD; Batra SK
    Am J Gastroenterol; 1983 May; 78(5):265-8. PubMed ID: 6846301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Argon beam plasma coagulation as therapy for high-grade dysplasia in Barrett's esophagus.
    Attwood SE; Lewis CJ; Caplin S; Hemming K; Armstrong G
    Clin Gastroenterol Hepatol; 2003 Jul; 1(4):258-63. PubMed ID: 15017666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barrett's esophagus and medications that relax the lower esophageal sphincter.
    Corley DA; Levin TR; Habel LA; Buffler PA
    Am J Gastroenterol; 2006 May; 101(5):937-44. PubMed ID: 16573773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential response to preoperative chemoradiation and surgery in esophageal adenocarcinomas based on presence of Barrett's esophagus and symptomatic gastroesophageal reflux.
    Agarwal B; Swisher SG; Ajani J; Kelly K; Komaki RR; Abu-Hamda E; Correa AM; Roth JA
    Ann Thorac Surg; 2005 May; 79(5):1716-23. PubMed ID: 15854962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The sequential model of Barrett's esophagus and adenocarcinoma induced by duodeno-esophageal reflux without exogenous carcinogens.
    Sato T; Miwa K; Sahara H; Segawa M; Hattori T
    Anticancer Res; 2002; 22(1A):39-44. PubMed ID: 12017320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Barrett's oesophagus: results from a 13-year surveillance programme.
    Bani-Hani K; Sue-Ling H; Johnston D; Axon AT; Martin IG
    Eur J Gastroenterol Hepatol; 2000 Jun; 12(6):649-54. PubMed ID: 10912484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survivin, a potential biomarker in the development of Barrett's adenocarcinoma.
    Vallböhmer D; Peters JH; Oh D; Kuramochi H; Shimizu D; Demeester SR; Hagen JA; Chandrasoma PT; Danenberg KD; DeMeester TR; Danenberg P
    Surgery; 2005 Oct; 138(4):701-6; discussion 706-7. PubMed ID: 16269299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barrett's esophagus and adenocarcinoma.
    Reid BJ; Weinstein WM
    Annu Rev Med; 1987; 38():477-92. PubMed ID: 3555308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenocarcinoma in Barrett's esophagus.
    Spechler SJ
    Compr Ther; 1987 Jun; 13(6):57-60. PubMed ID: 3581748
    [No Abstract]   [Full Text] [Related]  

  • 19. [Adenocarcinoma complication Barrett's esophagus: report of 5 cases (author's transl)].
    Audebert M; Huguier M; Luboinski J; Latrive JP; Gendre JP; Le Quintrec Y
    Gastroenterol Clin Biol; 1980 Nov; 4(11):765-9. PubMed ID: 7461388
    [No Abstract]   [Full Text] [Related]  

  • 20. The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years.
    Drewitz DJ; Sampliner RE; Garewal HS
    Am J Gastroenterol; 1997 Feb; 92(2):212-5. PubMed ID: 9040193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.